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Industrial fish production exposes fish to many potential stressful conditions, which in 16
turn may induce infections by opportunistic pathogens. Probiotics appear to be a 17
promising way to prevent opportunistic infections in aquaculture. In this study, we tested 18
the inhibitory potential of mucus endogenous bacterial community of brook charr 19
(Salvelinus fontinalis) against two major pathogens Flavobacterium columnare and 20
Flavobacterium psychrophilum. Nine bacterial strains were isolated from brook charr 21
skin mucus and tested for potential antagonistic activity. Results from both agar diffusion 22
assay and broth co-culture assay showed the presence of antagonism. We identified seven 23
bacterial strains, collected from unstressed fish, which exerted strong antagonism against 24
F.psychrophilum and/or F.columnare. Those strains were mixed and used to treat 25
columnaris disease in an in vivo experiment in which four distinct fish families were 26
tested. This treatment resulted in an substantial decrease of mortality (54% to 86%) 27
across fish families. Those results clearly indicate that directly deriving candidate from 28
the host microbiota is very suitable to develop probiotics. It thus allow to meet criteria for 29
an efficient and durable management of opportunistic diseases in aquaculture: ability to 30
adhere and colonize the host mucus, and an antagonistic effect against pathogen which is 31




Over the last decade, the aquaculture industry has greatly intensified its productivity and 35
is now a major economic and social activity in many countries (FAO 2007). Massive 36
production in fish farms may expose fish to stressful conditions (handling, high density, 37
transportation, poor water quality), which in turn induce infection by opportunistic 38
pathogens (Snieszko 1974; Barton and Iwama 1991; Wakabayashi 1991). Opportunistic 39
pathogens are naturally present in the water and harmless most of the time (Cahill 1990; 40
Crump et al. 2001). However, infection is triggered when the host encounters stressful 41
conditions. As a consequence, opportunistic infectious diseases constitute a major 42
problem for the aquaculture industry. For example, some strains of F. columnaris are able 43
to induce 100% mortality in 3 days salmon fingerlings (Michel et al. 1999; Pulkkinen et 44
al. 2010). 45
Infections are usually prevented and controlled by intrusive veterinary medicines and 46
chemical substances like synthetic antimicrobial agents (trimethoprim, sulphadiazine, 47
oxolinic acid, oxytetracycline hydrochloride and amoxycillin trihydrate) (Rangdale et al.48
1997). However, the beneficial effects of antimicrobial agents are counterbalanced by the 49
selection of resistant pathogens (Siegman-Igra et al. 1987; Decostere et al. 1997; 50
Decostere et al. 1998; Nematollahi et al. 2003) which gain resistance by horizontal 51
transfers of plasmids containing resistance genes (Lewin 1992; Sørum 2006; Hesami et 52
al. 2010). Therefore, alternative strategies to prevent opportunistic infections in 53
aquaculture are strongly needed. The development of probiotics appears to be the most 54
promising way to reach this goal (Verschuere et al. 2000; Merrifield et al. 2010). 55
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The definition 56
used to denote bacteria that promote the health of other organisms. In the aquaculture 57
context, a probiotic agent has been defined as a bacteria (viable or not) which improves 58
host health when added to the food or in the surrounding environment (Moriarty 1998). 59
The current strategy to develop probiotic for a given host species is to test a probiotic 60
agent already proven to be efficient in another host species (Villamil et al. 2003; 61
Mohamed and Ahmed Refat 2011). However, when transferred into a different 62
environment, the probiotic agent will likely lose its probiotic properties, and possibly 63
become harmful for the host (Courvalin 2006). Therefore, to ensure the harmlessness of a 64
probiotic in a given host species, it is 65
endogenous bacterial community (Balcazar et al. 2006). Probiotics improve host health 66
either by inducing the host immune response or by exerting direct inhibitory effects on 67
pathogens. Four action mechanisms of probiotics have been defined: i) competitive 68
exclusion (Garriques and Arevalo 1995; Moriarty 1997; Gomez-Gil et al. 2000; Balcazar 69
2003; Balcázar et al. 2004; Vine et al. 2004), ii) nutritional contribution (Sakata 1990; 70
Ringø et al. 1995), iii) influences on the environment (Dalmin et al. 2001), iv) 71
improvement of immune response and antimicrobial effect (Kamei et al. 1988; Sakai et 72
al. 1995; Rengpipat et al. 2000). Among these four inhibitory mechanisms, the 73
competitive exclusion is the most promising to look for probiotic candidates. Indeed, it is 74
more difficult for a given pathogen to adapt to the different factors involved in 75
competitive exclusion mechanisms than to a single specific antimicrobial substance76
(Smith 1993; Moriarty 1998). The usual experimental procedure to screen for candidate 77
probiotics is to perform in vitro antagonism tests to evaluate capabilities for production of 78
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inhibitory compounds, adhesion to the host or pathogen, and competition for nutrients 79
(Gram et al. 1999; Hjelm et al. 2004; Vine et al. 2004; Chabrillón et al. 2005).80
The present study focused on two important opportunistic pathogens in salmonids, 81
namely Flavobacterium columnare and Flavobacterium psychrophilum (Durborow et al.82
1998; Crump et al. 2001; Bernardet and Bowman 2006). Brook charr (Salvelinus 83
fontinalis), is a species that supports a promising aquaculture production in eastern 84
Canada, was retained as a host model (MPO 2005). The skin microflora was targeted 85
because isolates from other parts of the body (e.g. gut) are known to be inefficient to86
inhibit growth of skin pathogens (Spanggaard et al. 2001). Skin mucus offers both 87
physical and biochemical barriers and is then the first line of defense against pathogens. 88
Many innate immune factors are released in epidermal fish mucus including proteases, 89
antibacterial agents, and other related immune compounds (Hjelmeland et al. 1983; Fast90
et al. 2002; De Veer et al. 2007). These factors respond to stress and diseases. For 91
example, in Salmo salar, infection with sea lice induces an increase in related immune 92
compounds, namely lysozyme, alkaline phosphatase and activate proteolytic activities, 93
which in turn induce a part of the immune response to sea lice infection (Ross et al. 2000; 94
Fast et al. 2002; Easy and Ross 2009). Therefore, when investigating for direct inhibitory 95
mechanisms of probiotic candidates, it is important to distinguish between host immune 96
response and endogenous bacterial inhibitory effects. 97
Microbial communities were observed to be sensitive to various stressful environmental 98
conditions (Schimel et al. 2007). For example, corals bleaching is the direct consequence 99
of the global warming (Littman et al. 2010). In this respect, we hypothesized that stress 100
may unbalance the bacterial community structure of brook charr skin mucus which would 101
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in turn trigger opportunistic infections. Therefore, our general aim was to test whether 102
natural isolates of non-stressed skin mucus bacterial community exhibit competitiveness 103
for nutrient against two pathogens F.columnare and F.psychrophilum.104
The specific objectives were: i) to test the presence of inhibitory compounds in brook 105
charr skin mucus; ii) to evaluate the competitiveness of eight microbial isolates from skin 106
mucus against F.columnare and F.psychrophilum for nutrients, iii) to determine which 107
defensive mechanism was exerted, i.e. competitive exclusion or synthesis of 108
antimicrobial substances, iv) to confirm the in vitro effectiveness of our candidates on an 109
in vivo experiment for aquaculture application.110
EXPERIMENTAL PROCEDURE111
SAMPLING OF BROOK CHARR BACTERIAL COMMUNITY112
Sixteen fish families were raised in the Laboratoire Régional des Sciences Aquatiques 113
(LARSA) at the Laval University. Among them, two families were collected from a 114
stress experiment. A total of 2 individuals per family were sampled. One of them was 115
previously exposed to stress physiological conditions. Skin mucus was sampled using a 116
sterile razor blade and homogenized after addition of 9ml of sterile water.117
IDENTIFICATION OF THE BACTERIAL ISOLATES118
Fish mucus was diluted in sterile water from a 10 fold to a 10-7 dilution. Dilutions were 119
spread on TSA and R2A media. Bacterial colonies were isolated and individualized by 120
cross streaking and incubated at 20°C for 48H. A total of nine isolates was identified by 121
16S rDNA sequencing. Colonies were used as template DNA for PCR amplification of 122
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the 16S rRNA gene using the universal bacterial primers 63F -123
CAGGCCTAACACATGCAAGTC- (Marchesi et al. 1998) -124
CCGTCAATTCMTTTRAGTTT- (Lane et al. 1985). PCRs were carried out in a 125
volume of 25 µL containing 0.2 mM dNTP (Promega), 0.3 µM each primer, 6.4 µg of 126
BSA, 1.25 mM of MgCl2, 1X of Buffer and 0.4U of Taq DNA polymerase (Promega) 127
and performed in a Biometra T1 Thermocycler. The following amplification conditions 128
were applied: a first step of initial denaturation at 94 °C for 5 min followed by 28 cycles 129
of 94°C for 1 min, 55°C for 1min, 72°C for 90 sec and a final extension step at 72°C for 130
10 min. PCR products were analyzed by agarose gel electrophoresis [0.8% (w/v) agarose, 131
100 V] with ethidium bromide staining and visualized using an UV transilluminator. 132
Then, fragments were sequenced using the big Dye terminator V3 chemistry and ran on 133
an ABI 134
Biomoleculaire (IBIS, Laval University).135
MEDIA USED FOR CULTURE AND COMPETITION ASSAY136
Three general growth media, TSB (EMD), R2A (Difco) and TSA (Difco) were used for 137
isolation, identification, and culture of brook charr bacterial community isolates. Both 138
pathogens were grown on their respective general growth media, i.e. Anacker and ordal 139
(AO) (Anacker and Ordal 1959). This media was used for competition assays with 140
pathogens, Flavobacterium columnare (ATCC 49418) and Flavobacterium 141
psychrophilum (ATCC 49512) isolated from Oncorhynchus kisutch and Salmo trutta) 142
(Bernardet and Grimont 1989).143
SCREENING FOR ANTAGONISTIC EFFECT IN AGAR DIFFUSION ASSAY144
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All host bacterial isolate strains were tested for antagonistic effects with well diffusion 145
assays against F. columnare and F. Psychrophilum. Melted AO cooled to 45°C was 146
inoculated with each pathogen to a final density of 106 cells.mL-1 agar and poured into 147
Petri dishes (Gram and Melchiorsen 1996). A volume of 10 µL of probiotic candidate148
culture was added into a 3mm well punched in the solidified agar plates. Plates were 149
incubated at 20°C and observed for zones of growth around the wells during 48 h 150
(Spanggaard et al. 2001). Individual strains that exhibited competition capabilities were 151
then mixed in three co-cultures: two co-cultures containing the same quantity of all 152
strains with specific antagonistic effect against each pathogen F.columnare and 153
F.psychrophilum (culture C and culture P) and one co-culture with all strains with 154
antagonistic effect against the two pathogens (culture U). These three co-cultures (30 µL) 155
were added into 3 mm wells punched in the solidified agar plates, and observed for zones 156
of growth around the wells during 48 hr to check potential synergetic co-culture effects 157
(Timmerman et al. 2004).158
SCREENING FOR ANTAGONISTIC EFFECT IN BROTH CO-CULTURE ASSAY159
All antagonistic effects observed in the diffusion agar assay were validated by a broth co-160
culture assay. Candidates (104 cells) were added to 1 mL of AO media in competition 161
with 104 cells of the pathogen. These co-cultures were made in triplicates and incubated 162
48h at 20°C. Two mono-cultures of 104 cells of each pathogen acted as controls. Growth 163
of both candidates and pathogens was observed by spreading the co-culture on AO agar 164
plate along with morphological identification and counting.165
SCREENING FOR ANTAGONISTIC EFFECT OF MUCUS PROTEINS166
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Forty-three fish were sampled and all mucus samples were mixed and sterilized with UV 167
light during 25 min to minimizing degradation of proteins (Williams and Kraus 1963). 45 168
µL of mucus were added to 5 µL (500 cells) of pathogen culture in AO, spread on AO 169
agar plate and incubated at 20°C for 48h days. After incubation, culture was spread on 170
AO agar to observe the growth of pathogen. A volume of 45 µL of PBS mixed with 5 µL 171
of pathogen culture acted as control.172
PROBIOTIC TREATMENT OF FISH INFECTION173
Seven strains selected for their antagonistic activity during the in vitro experiment were 174
tested together in a co-culture. Four different fish families were used for the in vivo175
experiment (S1, S5, S9, S10). Those families were split in four tanks, two controls and 176
two tests. All the individuals were juvenile and came from the 177
178
tension was always higher than 12 mg/L. Each tank contain between 103 and 110 fish. 179
Two weeks after transportation, the first symptoms appeared in all tanks and we started 180
the addition of the mix of probiotics candidates. The probionts were added in test tank to 181
reach the concentration of 105 cell ml-1 in water twice daily until the fish mortality 182
stabilized. Dead fish and moribund were checked for clinical symptoms of columnaris 183
disease. 184
STATISTICAL ANALYSIS185
Usually, mortality data are often analysed by mean comparison with analysis of variance 186
-test. Furt187
or generalized model with a clog-log link are more appropriate to analyze mortality. In 188
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our experiment, we observed low mortality so we focused on proportion of death in each 189
replicates during 21 days using the generalized linear model approach with a logit link 190
and a binomial distribution. The analysis was performed using the software R, version 191
2.12.2.192
RESULTS193
SCREENING OF THE ENDOGENOUS BROOK CHARR SKIN MICROBIOTA194
A total of nine bacterial colonies were identified by 16S rDNA gene sequence analysis 195
(Table 1). Among the nine strains, six were found on mucus culture isolated from both 196
stressed and non-stressed fish. Actinobacteria (Microbacteriaceae, Nocardiaceae and 197
Dietziaceae) was the predominant (6 strains) bacterial group that was isolated from skin 198
mucus. Proteobacteria (gamma and alpha subclass) was the second group isolated (3 199
strains). Both of these groups belong to gram-negative bacteria. Most of these bacteria 200
were isolated from skin on TSA, while Microbacteriaceae and Pseudomonadaceae were 201
isolated with R2A only.202
All strains except Pseudomonas peli were able to grow on AO agar and could then be 203
tested as probiotic candidates against F. columnare and F. psychrophilum as those two 204
pathogens only grow on AO agar.205
SCREENING FOR ANTAGONISTIC EFFECT OF PROBIOTIC CANDIDATE IN 206
AGAR DIFFUSION ASSAY207
The eight strains were screened for antagonistic effects with an agar diffusion assay 208
against the two pathogens, F. columnare and F. psychrophilum (Table 1). In all assays, 209
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growth circles were observed, and no inhibitory zones involving antimicrobial 210
compounds were found. Six strains (75% of the cultivable skin fish microflora: 211
Luteimonas aestuarii, Rhodococcus cercidiphylli, Microbacterium oxydans, Rhodococcus 212
qingshengii, Sphingopyxis bauzanensis, Dietzia maris) were more competitive (better 213
growth) than F. psychrophilum after a 48h incubation period. All strains isolated from 214
unstressed fish exhibited competitive capabilities against F. psychrophilum. Four strains 215
(50% of the cultivable skin fish microflora: Luteimonas aestuarii, Rhodococcus 216
qingshengii, Leucobacter luti, Dietzia maris) were more competitive than F columnare. 217
The specific co-cultures (C and P) were still competitive against the two pathogens, but 218
no synergetic effect was observed (P > 0.05). The co-culture U exhibited a stronger 219
inhibitory effect (p = 0.015) when compared to the expected mean value of mono-220
cultures. This can be associated to the growth of Microbacterium oxydans in mono-221
cultures. Indeed, all the strains included in the co-culture had similar growth in mono-222
culture (1.5 mm ± 0.5 mm) except Microbacterium oxydans, which had an expensive 223
growth in mono-culture (23 mm).224
VALIDATION OF ANTAGONISTIC EFFECT IN BROTH CO-CULTURE ASSAY225
In order to validate the presence of a competitive effect, the seven strains, which had 226
exhibited antagonistic effects, were tested in broth co-culture assay with the pathogens. 227
All candidates grew but no cells of pathogens were found after transfer on AO agar 228
plates, although pathogen growth was clearly observed in controls plates (table 2). The 229
antagonistic effect observed in broth co-culture thus further validates the probiotic 230
potential of all the eight isolates tested in agar diffusion assays.231
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SCREENING FOR ANTAGONISTIC EFFECT OF MUCUS PROTEIN232
Mucus of 43 fish was mixed, sterilized and spread on AO agar plate with 5 µl of each 233
pathogen to test for the presence of antagonistic effect caused by the secretion of 234
antibacterial peptides. Morphological analysis of colonies showed no contamination by 235
bacterial strains coming from mucus or other sources. Only colonies of the two pathogens 236
were found. Each pathogen showed a better growth with mucus complementation, 237
especially for F. psychrophilum (p < 2.2 10-16).238
IN VIVO ANTAGONISM AGAINST FLAVOBACTERIUM COLUMNARE239
Seven strains with inhibitory activity against the two pathogens were mixed in order to be 240
used in co-culture for the in vivo experiment. The dynamic of mortality was different 241
between the two conditions (cf fig. 1). The first death occurred at day 4 in the control 242
tanks but it occurred one day later in test tank. Then, the mortality stabilized at day 17 in 243
the control and day 18 with the probiotic treatment. The probiotic addition significantly 244
reduced the mortality in the test tank (p < 0.001). The four families responded differently 245
to the infection and to the probiotic treatment (p < 0.001) (cf fig 2). The family S9 246
exhibited a very high sensitivity to infection (24% of death in control tanks), S1 and S10 247
families showed a medium sensitive response (12.9 and 12.8% of death in control tanks), 248
and S9 family was strongly resistant (4.4% of death in control tanks). No significant 249




F. columnare and F. psychrophilum are known to be two majors pathogens in salmonids 253
farming (Bernardet 1997). Actually, the only way to prevent and treat infections caused 254
by these two pathogens consists in the addition of NaCl, formaldehyde or addition of 255
antibiotics. However, various antibiotic resistance genes have rapidly invaded pathogen 256
strains when fish were treated as described above (Schmidt et al. 2000; Thomas-Jinu and 257
Goodwin 2004). To our knowledge, this study is the first that combines probiotic 258
screening in skin microflora of brook charr, screening for the presence of inhibitory 259
in vivo validation.260
Nine bacterial strains were isolated and identified by cultivable methods with TSA and 261
R2A media. These strains represent 0.03 to 1.8 % of the total microbiota present in skin 262
mucus of brook charr (Boutin et al., unpublished). This result can be explained by the 263
difficulty to cultivate environmental bacteria. Indeed, Amann et al. (1990) estimated that 264
no more than 1% of the environmental bacterial communities are cultivable. In the 265
present study, the predominant bacterial group isolated from brook charr skin microbiota 266
was composed of three genera of Actinobacteria (Microbacteriaceae, Nocardiaceae, 267
Dietziaceae). Actinobacteria were known to be an abundant group in soil (Madigan et al.268
1996) but are also reported to be very abundant in freshwater (Glockner et al. 2000). This 269
suggests that predominance of Actinobacteria in our mucus samples can be explained by 270
the influence of surrounding water bacterial community on fish mucus (Cahill 1990). 271
Seventy-five percent of the skin isolates had antagonistic effects against F. 272
psychrophilum and 50% of skin isolates against F. columnare. Results from broth culture 273
14
assays clearly indicate that all seven strains have antagonistic effects on the growth and 274
the survival of the two pathogens. The results of the agar diffusion assays show that the 275
mechanism involved in antagonistic effect is a competitive exclusion or a synthesis of 276
non-diffusible antimicrobial. In this respect, no inhibition clearing was observed on agar 277
plates but growth circles were present. The seven strains have grown quickly during the 278
first 48h, despite the fact that pathogens have already colonized all the media.279
At first sight, the inhibition of growth and survival along with the absence of inhibitory 280
compounds in skin mucus, support the competitive exclusion hypothesis. This concept of 281
suppression of pathogens by the development of resident bacteria was firstly suggested 282
by Nurmi and Rantala (1973) in birds. The competitive exclusion exerted by probiotics 283
against pathogens was also reported in fish, crustaceans or other aquatics organisms 284
(Garriques and Arevalo 1995; Moriarty 1997; Gomez-Gil et al. 2000; Balcazar 2003; 285
Balcázar et al. 2004; Vine et al. 2004). Competitive exclusion is the most promising 286
mode of probiotic action because it involves many different processes and factors which 287
are very important in microbial dynamics (Smith 1993). In order to become more 288
competitive, pathogens need to evolve and gain new functions, each of them facing a 289
single process implied in the competition. On the contrary, when competitors inhibit 290
growth by secretion of a single antimicrobial agent, the pathogen needs to acquire only 291
one specific resistance gene to this specific antimicrobial agent (Moriarty 1998). 292
Furthermore, horizontal gene transfers mediated by plasmid vehicles favor quick and 293
frequent acquisitions of new antimicrobial resistance (Lewin 1992; Courvalin 2006; 294
Sørum 2006). However, in a competitive exclusion interaction, pathogen needs to evolve 295
more than a single resistance gene. This mechanism of adaptation is slower than a single 296
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plasmid transfer, therefore maintaining the status quo with the competing probiotic agent, 297
as formalized in the red queen theory (van Valen 1973).298
In a second way, the survival inhibition in the broth assay act in favor of a non-diffusible 299
antimicrobial compound. We first thought about bacteriocin or other protein like 300
compound because some studies on these compound shown similar results with false 301
negative on agar diffusion assay (Schillinger and Lucke 1989; Bromberg et al. 2004; 302
Oliveira et al. 2008). Nevertheless, the target of bacteriocin is the cytoplasmic membrane 303
and Gram-negative bacteria like Flavobacteria do have a protective barrier provided by 304
the lipopolysaccharide of the outer membrane. However, some conditions can disrupt the 305
integrity of this barrier and increase the effectiveness of bacteriocin against gram-306
negative bacteria (Stevens et al. 1991; Mortvedt-Abildgaard et al. 1995). The advantage 307
of bacteriocin and other protein-like compound is their sensitiveness to digestion enzyme 308
or protease activity. Indeed, those compounds are easily degradable and safe for human 309
consumption, which is not the case for antibiotics (Phillips et al. 2004; Courvalin 2006). 310
Further works to isolate and identify those compounds are necessary to clearly identify 311
the mechanisms involve in the in vitro antagonisms.312
Our seven candidates fulfilled the three criteria for a subsequent in vivo validation 313
experiment. First, they were all isolated from resident community of skin mucus. Second, 314
they were able to adhere and colonize the mucus. Third, they all exerted antagonistic 315
effect against pathogen by competitive exclusion (Verschuere et al. 2000). So they were 316
mixed and test in an in vivo experiment. The addition of those probiotics significantly 317
decreased the fish mortality. This result indicates that there is a good correlation between 318
our in vitro experiment and the in vivo experiment, meanwhile it is not the case for many 319
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studies (Reddy et al. 1994; Expert and Digat 1995; Gram et al. 2001). Nevertheless we 320
just test the effect in vivo against Flavobacterium columnare because the infection 321
occurred naturally after a stress due to the handling and not to a challenge against the 322
pathogen. Furthermore, the four families showed different intensity of response to the 323
treatment. A decrease of mortality occurred in all the families. Strikingly, the most 324
important decrease occurred in the most sensitive family. First, this result confirms 325
previous observations on Salvelinus fontinalis, showing that some families are more 326
sensitive than other to opportunistic infection (Bastien 2009). Second, this result is 327
further striking because it strongly suggests that host genotype controls the efficiency of 328
the probiotic effect on the pathogen. Knowing that microbiota composition is directly 329
influenced by the host genotype (Turnbaugh et al. 2007), we can therefore hypothesize 330
that some host genotypes are more tolerant to mutualism and let the probiotic colonize 331
their skin mucus. The hosted probiotic will in turn conferring a best protection to its host. 332
This mechanism is the basis of symbiosis and mutualism. 333
CONCLUSION334
Our results indicate that isolation of host specific strains is easily manageable and cost 335
effective: Seven of the nine strains collected from unstressed fish exerted strong 336
exclusive competition against both F. psychrophilum and/or F. columnare, which 337
suggests they are all promising probiotic candidates. To conclude, agar diffusion assays,338
combined with broth culture assay and the screening of inhibitory compound in mucus, 339
have clearly demonstrated that seven of our eight strains isolated from brook charr skin 340
mucus were able to exclude both F. columnare and/or F. psychrophilum. Nevertheless, 341
we were not able to identify clearly mechanisms involve in the exclusion. Two non-342
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exclusive hypothesis persist; i) Competition for nutrients, ii) Synthesis of bacteriocin or 343
other antimicrobial compound. The use of these seven probiotics in vivo clearly reduced 344
de mortality, therefore demonstrating the curative effect of these host specific strains. 345
These results show unambiguously that using of probiotic is a really manageable way to 346
efficiently prevent opportunistic infections. As a perspective, the efficiency of probiotic 347
action could be improved by combining a genetic selection program enhancing the 348
relationship between fish and probiotics. Further works on the impact of these probiotics 349
on the microbial load of fish and water are in progress and might explain the mechanism 350
involve in the antagonism observed in this study.351
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TABLES AND FIGURES LEGENDS574
Table 1. 16S rDNA gene sequence identification and capability to inhibit growth in nine 575
indigenous bacterial isolates from mucus skin of brook charr. All strains were found in 576
mucus from unstressed fish but only 6 were found in mucus from stressed fish. (+), 577
isolates grew; (-), isolates did not grow.578
579
Table 2. Bacterial counts of broth co-culture assays after 48h incubation. Each assay was 580
run in triplicate.581
582
Figure 1. Accumulated mortality of brook charr (all family taken together) infected by 583
Flavobacterium columnare and treated with probiotics candidates. Probiotic culture was 584
added to the tanks during the infection.585
Figure 2. Accumulated mortality for the four families of brook charr infected by 586
Flavobacterium columnare and treated with probiotics candidates. Probiotic culture was 587
added to the tanks during the infection.588
589
Isolates Media Growth on AO Physiological condition 
of host
Bacterial group Closest hit in 
GenBank













CP1 TSA + Unstressed Gamma-proteobacteria Luteimonas 
aestuarii
EF660758 98.899 1279 + +
CP2 TSA, R2A + unstressed, stressed Actinobacteria Microbacteriu
m hatanonis
AB274908 99.917 1215 - -
CP3 TSA + unstressed, stress Actinobacteria Rhodococcus 
cercidiphylli
EU325542 99.439 1247 - +
CP4 TSA, R2A + unstressed, stressed Actinobacteria Microbacteriu
m oxydans
Y17227 99.762 1260 - +
CP5 TSA + unstressed, stressed Actinobacteria Rhodococcus 
qingshengii
DQ090961 100.000 1248 + +
CP6 TSA, R2A - Unstressed Gamma-proteobacteria Pseudomonas peliAM114534 100.000 1264 NA NA
CP7 TSA + Unstressed Alpha-proteobacteria Sphingopyxis 
bauzanensis
GQ131578 99.129 1122 - +
CP8 TSA, R2A + unstressed, stressed Actinobacteria Leucobacter 
luti
AM072819 98.638 1254 + -
CP9 TSA + unstressed, stressed Actinobacteria Dietzia maris X79290 99.759 1249 + +
Isolates Pathogens Mean Count of isolatesMean Count of Pathogens
CP1 F.columnare 4.84E+09 0.00E+00
CP1 F.psychrophilum 3.63E+10 0.00E+00
CP3 F.psychrophilum 5.53E+10 0.00E+00
CP4 F.psychrophilum 7.10E+10 0.00E+00
CP5 F.columnare 8.70E+10 0.00E+00
CP5 F.psychrophilum 6.00E+11 0.00E+00
CP7 F.psychrophilum 1.39E+11 0.00E+00
CP8 F.columnare 2.37E+11 0.00E+00
CP9 F.columnare 8.33E+10 0.00E+00
CP9 F.psychrophilum 7.73E+10 0.00E+00
NA F.columnare NA 5.00E+09
NA F.psychrophilum NA 3.00E+09


